Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Discovery and Structure-Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P1).
Current and emerging treatment of multiple sclerosis.
Tp-Te interval predicts heart rate reduction after fingolimod administration in patients with multiple sclerosis.
Neuropathology Associated With Diffuse Excessive High Signal Intensity Abnormalities on Magnetic Resonance Imaging in Very Preterm Infants.
Suspected Acoustic Neuroma Demyelinating Lesions.
Increasing prevalence of multiple sclerosis in Buenos Aires, Argentina.
Treatment of spontaneous EAE by laquinimod reduces Tfh, B cell aggregates, and disease progression.
Blockade of Glutamine Synthetase Enhances Inflammatory Response in Microglial Cells.
The role of sleep on cognition and functional connectivity in patients with multiple sclerosis.
Is it worth to report the presence of a single and additional band in the cerebrospinal fluid detected by isoelectrofocusing?
Benefit-Risk of Therapies for Relapsing-Remitting Multiple Sclerosis: Testing the Number Needed to Treat to Benefit (NNTB), Number Needed to Treat to Harm (NNTH) and the Likelihood to be Helped or Harmed (LHH): A Systematic Review and Meta-Analysis.
MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study.
Merging Transport Data for Choroid Plexus with Blood-Brain Barrier to Model CNS Homeostasis and Diseases More Effectively.
Regarding the past, what is the trial you have always been dreaming of in CIDP?
Neurological Nuance: Hodgkin Lymphoma Presenting With Guillain-Barré Syndrome.
[Relationship between serum erythropoietin levels and brain injury in preterm infants].
Docosahexaenoic Acid Reduces Cerebral Damage and Ameliorates Long-Term Cognitive Impairments Caused by Neonatal Hypoxia-Ischemia in Rats.
Mass Spectrometry-Based Quantitative Strategies for Assessing the Biological Consequences and Repair of DNA Adducts.
From Natural Product to the First Oral Treatment for Multiple Sclerosis: The Discovery of FTY720 (Gilenya™)?
Meeting the mental health needs of people with multiple sclerosis: a qualitative study of patients and professionals.
Whole Exome Sequencing Identifies the Genetic Basis of Late-Onset Leigh Syndrome in a Patient with MRI but Little Biochemical Evidence of a Mitochondrial Disorder.
Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United Kingdom.
Smoking as a risk factor for developing Multiple Sclerosis: A meta-analysis of observational studies.
The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?
The Perceived Deficits Questionnaire: Perception, Deficit, or Distress?

Pages